RxDoctor Payments Data

Jeffrey Jackson, PA

Physician Assistant · Eau Claire, WINPI 1730281429

Payments from drug & device makers

$1,518in general payments, 2019–2025

Across 81 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$352
  • Alkermes, Inc.$247
  • Lundbeck LLC$247
  • Neurocrine Biosciences, Inc.$202
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$116
  • Takeda Pharmaceuticals U.S.A., Inc.$78
  • plus $275 from 7 others

What the payments were for

  • Food & beverage$1,47197%
  • Education$473%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,518 in reported general payments places this provider in the 90th percentile of 2,804 physician assistant providers in Wisconsin.

See all physician assistant providers in Wisconsin

Medicare billing

Part B allowed, 2024
$17,766
Medicare patients
80
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate28$220,598
TrintellixVortioxetine Hydrobromide15$19,286
Aripiprazole135$16,831
Lurasidone Hcl37$12,746
FanaptIloperidone11$12,137
Ziprasidone Hcl101$11,083
Divalproex Sodium ErDivalproex Sodium143$7,360
Bupropion XlBupropion Hcl230$5,567
Fluphenazine Hcl37$5,335
Quetiapine Fumarate264$4,200
Venlafaxine Hcl ErVenlafaxine Hcl171$3,966
Paliperidone ErPaliperidone12$3,767
Carbamazepine ErCarbamazepine31$3,693
Duloxetine Hcl97$3,354
Haloperidol123$2,501

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$202$220,59828 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$78$19,28615 claims
Vanda Pharmaceuticals Inc.Fanapt$14$12,13711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,804 physician assistant providers in Wisconsin.

Other physician assistant in Eau Claire

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →